INVITAE CORP (NVTA) Stock Price, Quote, News and Overview
NYSE:NVTA - New York Stock Exchange, Inc. - US46185L1035 - Common Stock - Currency: USD
NVTA Quote, Performance and Key Statistics
NYSE:NVTA (2/5/2024, 7:40:05 PM)
0.0891
-0.3 (-77.12%)
The current stock price of NVTA is 0.0891 USD. In the past month the price decreased by -82.72%. In the past year, price decreased by -95.72%.
NVTA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 10.97 | 82.08B | ||
| CVS | CVS HEALTH CORP | 11.71 | 79.88B | ||
| LH | LABCORP HOLDINGS INC | 17.15 | 20.84B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.1 | 19.12B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.74 | 13.55B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.77 | 12.18B | ||
| DVA | DAVITA INC | 14.99 | 11.68B | ||
| HIMS | HIMS & HERS HEALTH INC | 112 | 10.77B | ||
| CHE | CHEMED CORP | 23.84 | 8.18B | ||
| CRVL | CORVEL CORP | 25.97 | 5.57B | ||
| OPCH | OPTION CARE HEALTH INC | 26.89 | 5.45B | ||
| GH | GUARDANT HEALTH INC | N/A | 5.30B |
Related stock screener links
About NVTA
Company Profile
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. The company is headquartered in San Francisco, California and currently employs 1,700 full-time employees. The company went IPO on 2015-02-12. The firm is engaged in delivering genetic testing services, digital health solutions, and health data services that support a lifetime of patient care and improved outcomes. The company offers genetic testing across multiple clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases and pharmacogenomics. The company applies proprietary design, process automation, robotics and bioinformatics software solutions to expand the use and impact of genetic information in sample processing and complex variant interpretation, allowing medical interpretation at scale. The firm also utilizes digital health solutions to improve ease-of-use and to deliver actionable information about risk, prevention, treatment, and monitoring. The firm has served over 3.6 million patients, and over 2.2 million of those patients have made their information available for data sharing.
Company Info
INVITAE CORP
1400 16Th Street
San Francisco CALIFORNIA 94103 US
CEO: Sean E. George
Employees: 1700
Company Website: https://www.invitae.com
Phone: 14153747782
INVITAE CORP / NVTA FAQ
What is the stock price of INVITAE CORP today?
The current stock price of NVTA is 0.0891 USD. The price decreased by -77.12% in the last trading session.
What is the ticker symbol for INVITAE CORP stock?
The exchange symbol of INVITAE CORP is NVTA and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is NVTA stock listed?
NVTA stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for INVITAE CORP stock?
13 analysts have analysed NVTA and the average price target is 0.72 USD. This implies a price increase of 712.79% is expected in the next year compared to the current price of 0.0891. Check the INVITAE CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is INVITAE CORP worth?
INVITAE CORP (NVTA) has a market capitalization of 25.53M USD. This makes NVTA a Nano Cap stock.
How many employees does INVITAE CORP have?
INVITAE CORP (NVTA) currently has 1700 employees.
Is INVITAE CORP (NVTA) expected to grow?
The Revenue of INVITAE CORP (NVTA) is expected to decline by -6.03% in the next year. Check the estimates tab for more information on the NVTA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy INVITAE CORP (NVTA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NVTA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NVTA, evaluating the profitability, health, valuation and growth aspects
- INVITAE CORP (NVTA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- INVITAE CORP (NVTA) Sales and EPS estimates to see what analysts future expectations are.
- INVITAE CORP (NVTA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- INVITAE CORP (NVTA) Insider and Institutional Ownership to learn about the owners and their transactions.
- INVITAE CORP (NVTA) Stock Chart to make your own analysis
- INVITAE CORP (NVTA) Latest news and press-releases to stay up to date.
Does INVITAE CORP (NVTA) stock pay dividends?
NVTA does not pay a dividend.
When does INVITAE CORP (NVTA) report earnings?
INVITAE CORP (NVTA) will report earnings on 2024-02-21, after the market close.
What is the Price/Earnings (PE) ratio of INVITAE CORP (NVTA)?
INVITAE CORP (NVTA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.11).
NVTA Technical Analysis
NVTA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NVTA. NVTA has a bad profitability rating. Also its financial health evaluation is rather negative.
NVTA Financial Highlights
Over the last trailing twelve months NVTA reported a non-GAAP Earnings per Share(EPS) of -1.11. The EPS increased by 58.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -269.22% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NVTA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 46% to NVTA. The Buy consensus is the average rating of analysts ratings from 13 analysts.
For the next year, analysts expect an EPS growth of 53.25% and a revenue growth -6.03% for NVTA